Multiple myeloma trials in Bosnia & Herzegovina
1 trial · From ClinicalTrials.gov, checked 10 Nov 2026. Ask the study team whether a trial fits you.
Phase 3RecruitingTrial-stage medicine
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
- Where
- Banja Luka, Mostar, Sarajevo
- Age
- 18 years and over
- People
- 386 worldwide
- Run by
- Grifols Therapeutics LLC
See details and how to joinNCT05645107EU 2022-502193-16-00Registry updated 2026-09-30
All Multiple myeloma trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.